[Skip to Content]
[Skip to Content Landing]
July 23, 1982

Antiarrhythmic Effects of Tricyclic Antidepressants-Reply

Author Affiliations

Wadsworth Veterans Administration Medical Center UCLA School of Medicine Los Angeles

JAMA. 1982;248(4):429. doi:10.1001/jama.1982.03330040023023

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


In Reply.—  We thank Drs Thase and Perel in suggesting that we add imipramine and other tricyclic antidepressants to the growing list of newer antiarrhythmic drugs. In our review, the intent was not to discuss all new antiarrhythmic drugs. Rather, it was to present, in a brief compass, the salient features of those compounds that have been studied somewhat extensively. For this reason, we did not describe the properties or the role of the tricyclic compounds pirmenol hydrochloride, cibenzoline, sotalol, clofilium phosphate, propafenone, or moricizine. Undoubtedly, ongoing studies will clarify the relative merits and roles of these compounds in the control of disorders of cardiac rhythm.